Volume 28 - Issue 9 - September 2020
Cover Story
09/11/2020
Sasha D. Jaquez, PhD; Maria A. Leszczynska, MD
Bullying is common in childhood, and children with visible skin conditions can be highly vulnerable. Dermatologists can play a critical role into helping their pediatric patients through early screening and management.
Bullying is common in childhood, and children with visible skin conditions can be highly vulnerable. Dermatologists can play a critical role into helping their pediatric patients through early screening and management.
Bullying is common in childhood,...
09/11/2020
The Dermatologist
Board Review
09/11/2020
Amy J. McMichael, MD
The contents of these questions are taken from the Galderma Pre-Board Webinar. The Pre-Board Webinar is now an online course. For details, go to http://www.galdermausa.com/Our-Commitment/PreBoard-Webinar.aspx.
The contents of these questions are taken from the Galderma Pre-Board Webinar. The Pre-Board Webinar is now an online course. For details, go to http://www.galdermausa.com/Our-Commitment/PreBoard-Webinar.aspx.
The contents of these questions...
09/11/2020
The Dermatologist
Chief Medical Editor Message
09/11/2020
Steven R. Feldman, MD, PhD
I like to say that medical care is more than just making the right diagnosis and prescribing the right treatment. To get patients well, you also have to get patients to take the medication. Yet those three pillars of medicine—the right...
I like to say that medical care is more than just making the right diagnosis and prescribing the right treatment. To get patients well, you also have to get patients to take the medication. Yet those three pillars of medicine—the right...
I like to say that medical care...
09/11/2020
The Dermatologist
Letters to the Editor
09/11/2020
Robert Colton, MD
It’s wonderful to see this discussion about value-based care models (VBCMs). I appreciate Dr Buka’s response to my article1 and thanks to Ms Brillstein for continuing the dialogue.2
I agree with Ms Brillstein...
It’s wonderful to see this discussion about value-based care models (VBCMs). I appreciate Dr Buka’s response to my article1 and thanks to Ms Brillstein for continuing the dialogue.2
I agree with Ms Brillstein...
It’s...
09/11/2020
The Dermatologist
News
09/11/2020
FDA Approves First Topical Androgen Receptor Inhibitor for Acne;
FDA Approves First Topical Androgen Receptor Inhibitor for Acne;
FDA Approves First Topical...
09/11/2020
The Dermatologist
Derm Dx
09/11/2020
Nasir Aziz, MD; David Ahn, MD
A 67-year-old Ethiopian woman presented with a large black plaque surrounded by several smaller violaceous papules on her frontal hairline for 6 months (Figure). The largest plaque was tender and occasionally...
A 67-year-old Ethiopian woman presented with a large black plaque surrounded by several smaller violaceous papules on her frontal hairline for 6 months (Figure). The largest plaque was tender and occasionally...
A...
09/11/2020
The Dermatologist
Spotlight
09/11/2020
Benjamin Barankin, MD, FRCPC
Dr Greenberg is the founder of Las Vegas Dermatology and assistant professor of internal medicine (IM) at the University of Nevada Las Vegas School of Medicine. Since before his IM certification lapsed, Dr Greenberg has been a champion of a...
Dr Greenberg is the founder of Las Vegas Dermatology and assistant professor of internal medicine (IM) at the University of Nevada Las Vegas School of Medicine. Since before his IM certification lapsed, Dr Greenberg has been a champion of a...
Dr Greenberg is the founder of...
09/11/2020
The Dermatologist
Business Insider
10/05/2020
Nick Hernandez, MBA, FACHE
Practice valuation nomenclature has changed over the years. Practice values used to be referred to as a percentage of collections, but today’s most common reference point is a multiple of earnings before interest,...
Practice valuation nomenclature has changed over the years. Practice values used to be referred to as a percentage of collections, but today’s most common reference point is a multiple of earnings before interest,...
...
10/05/2020
The Dermatologist
Partner Approved
09/11/2020
Lauren Mateja
Lynn McKinley-Grant, MD, FAAD details what you need to remember when diagnosing and treating psoriasis in patients of color.
Lynn McKinley-Grant, MD, FAAD details what you need to remember when diagnosing and treating psoriasis in patients of color.
Lynn McKinley-Grant, MD, FAAD...
09/11/2020
The Dermatologist
Partner Approved
09/11/2020
Peter Sonnenreich
New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.
New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.
New biologic therapy...
09/11/2020
The Dermatologist
Partner Approved
09/11/2020
Peter Sonnenreich
New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.
New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.
New biologic therapy...
09/11/2020
The Dermatologist
